Clinical trial
MENDS Study: Trial in Ventilated ICU Patients Comparing an Alpha2 Agonist Versus…
NCT00095251 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00095251 |
|---|---|
| Title | MENDS Study: Trial in Ventilated ICU Patients Comparing an Alpha2 Agonist Versus a Gamma Aminobutyric Acid (GABA)-Agonist to Determine Delirium Rates, Efficacy of Sedation, Analgesia and Discharge Cognitive Status |
| Official title | A Randomized, Double-blind Trial in Ventilated ICU Patients Comparing Treatment With an Alpha2 Agonist Versus a Gamma Aminobutyric Acid (GABA)-Agonist to Determine Delirium Rates, Efficacy of Sedation, Analgesia and Discharge Cognitive Status |
| Lead sponsor | Vanderbilt University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Delirium |
| Intervention type | Drug |
| Interventions | Dexmedetomidine, Lorazepam |
| Enrollment | 100 |
| Start date | Aug 1, 2004 |
| Primary completion | Aug 1, 2007 |
| Completion | Dec 1, 2016 |
| First posted | Nov 2, 2004 |
| Last update posted | Sep 11, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: